Intelligent Bio Solutions (INBS) announced that it will effect a 1-for-10 reverse split of its common stock, that will become effective at 11:59 pm Eastern Time on December 15. Trading of the company’s common stock on Nasdaq will continue, on a split-adjusted basis, with the opening of the markets on December 16, under the trading symbol “INBS” and new CUSIP number 36151G709. The reverse stock split was approved by Intelligent Bio Solutions’ stockholders at the annual meeting of the company’s stockholders held on October 16, with the final ratio to be determined by the company’s board of directors within the ratio range authorized by shareholders, the company noted.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on INBS:
- Intelligent Bio Solutions Presents Investor Update
- Intelligent Bio Solutions Issues Restricted Shares for Advisory
- Intelligent Bio Solutions reports Q1 EPS (35c) vs (70c) last year
- Intelligent Bio expects to report Q1 revenue growth of 32% sequentially
- Intelligent Bio Solutions Adds 33 New Customer Accounts
